RedHill Biopharma Ltd. — Investor Relations & Filings
RedHill Biopharma is a specialty biopharmaceutical company focused on the development and commercialization of proprietary, orally-administered, small molecule drugs. The company's primary therapeutic areas of focus are gastrointestinal (GI) diseases, infectious diseases, and oncology. Its key commercial product is Talicia® for the treatment of Helicobacter pylori (H. pylori) infection. RedHill's late-stage clinical development pipeline includes several drug candidates. Among these are Opaganib, a broad-acting, host-directed antiviral and anti-inflammatory agent; RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease; and RHB-107 (upamostat), an oral serine protease inhibitor. A significant part of its strategy involves developing its assets for pandemic preparedness and as medical countermeasures, emphasizing therapies with viral mutation-resistant properties suitable for stockpiling.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 20-F | 2014-02-25 | English | |
| FORM 6-K FILING DOCUMENT | 2014-02-25 | English | |
| SCHEDULE 13D/A | 2014-02-10 | English | |
| SCHEDULE 13G/A | 2014-02-10 | English | |
| FORM SC 13G/A | 2014-02-06 | English | |
| FORM SC 13G/A | 2014-02-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2014
15 filings
| |||||
| 12581201 | FORM 20-F | 2014-02-25 | English | ||
| 12581202 | FORM 6-K FILING DOCUMENT | 2014-02-25 | English | ||
| 12581203 | SCHEDULE 13D/A | 2014-02-10 | English | ||
| 12581204 | SCHEDULE 13G/A | 2014-02-10 | English | ||
| 12581205 | FORM SC 13G/A | 2014-02-06 | English | ||
| 12581206 | FORM SC 13G/A | 2014-02-06 | English | ||
| 12581207 | FORM SC 13G/A | 2014-02-06 | English | ||
| 12581208 | FORM SC 13G/A | 2014-02-06 | English | ||
| 12581210 | Regulatory Filings 2014 | 2014-02-05 | English | ||
| 12581209 | PROSPECTUS | 2014-02-04 | English | ||
| 12581211 | FORM 6-K FILING DOCUMENT | 2014-02-04 | English | ||
| 12581212 | SC 13G | 2014-02-03 | English | ||
| 12581213 | FORM 6-K | 2014-02-03 | English | ||
| 12581214 | SC 13G | 2014-01-30 | English | ||
| 12581215 | FORM 6-K | 2014-01-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
RedHill Biopharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35302/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35302 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35302 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35302 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35302}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for RedHill Biopharma Ltd. (id: 35302)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.